Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men
APACHES
Natural History of Anal Human Papillomavirus Infection and Associated Disease in HIV-infected Men Who Have Sex With Men: Towards an Evidence Base for the Prevention of Anal Cancer.
1 other identifier
interventional
516
1 country
1
Brief Summary
Multicentric epidemiological non-comparative study in France characterising evolution of anal Human papillomavirus (HPV) infection and related lesions and evaluating markers associated with the observed evolution. Estimated enrolment: 500 Principal Outcomes
- Detection of high-grade cytological and histological anal lesions by high resolution anoscopy
- Spontaneous regression of high-grade anal lesions
- Detection of anal HPV infection Intervention (procedure):
- Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
- Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits)
- High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA): \- anal biopsy(ies) during HRA Only if high-grade lesion: \- HRA biannually
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2014
CompletedFirst Posted
Study publicly available on registry
November 11, 2014
CompletedStudy Start
First participant enrolled
December 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedApril 23, 2026
April 1, 2026
7.6 years
October 15, 2014
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Evaluation of high-grade anal lesions by high resolution anoscopy
Initial inclusion visit
Evaluation of anal HPV infection by DNA, RNA and protein detection
Initial inclusion visit
Quantification of spontaneous regression of high-grade anal lesions
Month 24
Secondary Outcomes (4)
Evaluation of anal HPV infection by DNA, RNA and protein detection
Month 6
Evaluation of anal HPV infection by DNA, RNA and protein detection
Month 12
Evaluation of anal HPV infection by DNA, RNA and protein detection
Month 18
Evaluation of anal HPV infection by DNA, RNA and protein detection
Month 24
Study Arms (1)
Subjects
OTHER* Standard proctologic examination with digital rectal examination and 2 anal swabs at initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits * High resolution anoscopy at initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits * Biopsy(ies) during High Resolution Anoscopy only if lesion suggestive of AIN detected during High Resolution Anoscopy * High Resolution Anoscopy biannually only if high-grade lesion (ASC-H, HSIL ou AIN2/3)
Interventions
(with digital rectal examination and 2 anal swabs) at initial inclusion visit, M12 and M24 follow-up visits and if applicable M6 and M18 control visits
at initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits
only if lesion suggestive of AIN detected during High Resolution Anoscopy
Only if high-grade lesion (ASC-H, HSIL ou AIN2/3)
Eligibility Criteria
You may qualify if:
- Men who have sex with men
- At least 35 years old
- HIV-positive (documented search of HIV infection, with HIV status determined according to HAS algorithm)
- Signed informed consent
- Affiliated to or beneficiary of French social security
- All severity criteria and evolution of HIV disease are accepted (including AIDS stage and co-infections)
You may not qualify if:
- Contraindication to biopsy
- History of anal cancer or pelvic radiotherapy
- AIN2/3 treated during previous year
- Difficulty in evaluation (anus reshaped and/or scarred)
- Individual placed under judicial protection
- Foreseen absence which may hamper participation; insufficient motivation; associated pathology with priority for care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diaconesses
Paris, France
Related Publications (4)
Combes JD, Didelot JM, Radenne S, Zaegel-Faucher O, Lesage AC, Siproudhis L, Piroth L, Marchand L, Heard I, Hoyeau N, Henno S, Darragh TM, Alberts CJ, Clifford GM, Etienney I; ANRS-EP57-APACHES Study group. Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in France. J Infect Dis. 2024 Jul 25;230(1):55-60. doi: 10.1093/infdis/jiad506.
PMID: 39052708BACKGROUNDAlberts CJ, Heard I, Canestri A, Marchand L, Flejou JF, Piroth L, Ferry T, Didelot JM, Siproudhis L, Henno S, Poizot-Martin I, Darragh TM, Clifford GM, Combes JD, Etienney I; ANRS EP57 APACHES Study group. Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in France. J Infect Dis. 2020 Apr 7;221(9):1488-1493. doi: 10.1093/infdis/jiz623.
PMID: 31754686RESULTClifford GM, Siproudhis L, Piroth L, Poizot-Martin I, Radenne S, Reynes J, Lesage A, Heard I, Henno S, Flejou JF, Marchand L, Combes JD, Etienney I; ANRS EP57 APACHES Study group. Determinants of high-grade anal intraepithelial lesions in HIV-positive MSM. AIDS. 2018 Oct 23;32(16):2363-2371. doi: 10.1097/QAD.0000000000001947.
PMID: 30005009RESULTCombes JD, Heard I, Poizot-Martin I, Canestri A, Lion A, Piroth L, Didelot JM, Ferry T, Patey O, Marchand L, Flejou JF, Clifford GM, Etienney I; ANRS EP57 APACHES Study group. Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus-Positive Men Who Have Sex with Men. J Infect Dis. 2018 Apr 23;217(10):1535-1543. doi: 10.1093/infdis/jiy059.
PMID: 29394362RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabelle Etienney
Hôpital Diaconesses Paris
- STUDY DIRECTOR
Gary Clifford
International Agency for Research on Cancer
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2014
First Posted
November 11, 2014
Study Start
December 2, 2014
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
April 23, 2026
Record last verified: 2026-04